Top Markets
Coin of the day
Minerva Surgical, Inc. Minerva Surgical, Inc.

Minerva Surgical, Inc.

UTRS
Rank in Stocks #42552
Minerva Surgical, Inc. functions as a commercial-stage medical technology... Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$888.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Minerva Surgical, Inc. (UTRS)

Category

Stock price history for Minerva Surgical, Inc. (UTRS)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $182.60 on 2021-10-01
Stock price history of Minerva Surgical, Inc. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 652.85%
2024 -100.00%
2023 -47.46%
2022 -96.29%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$72.70 -3.49%
US
$127.97 -34.22%
AU
$60.14 168.60%
US
$53.98 -22.48%
US
$30.49 0.00%
US